Getting to the source of schizophrenia

Characterization of [3H]MCL-524, a Potent Dopamine D2 high Receptor Agonist.

ACS omega·2026

The High Affinity Dopamine D2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders.

ACS chemical neuroscience·2021

New Dopamine D2 Receptor Agonist, [3H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.

ACS chemical neuroscience·2018

Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States.

Journal of chemical information and modeling·2018

Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.

ACS chemical neuroscience·2017

Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.

ACS chemical neuroscience·2016

Population Avoidable Days: A Novel Approach to an Old Problem.

Healthcare quarterly (Toronto, Ont.)·2026

Ambient Artificial Intelligence Scribes in Healthcare: A Governance Imperative for Canadian Health System Leaders.

Healthcare quarterly (Toronto, Ont.)·2026

Optimizing Opioid Addiction Treatment in Correctional Centres: Learnings From Alberta, Canada.

Healthcare quarterly (Toronto, Ont.)·2026

Toward a Quality Standard for Emergency Departments: A Commentary on Improving Mental Health and Substance Use Care for Youth in Canada.

Healthcare quarterly (Toronto, Ont.)·2026

Advancing a Digitally Enabled Supply Chain as a Strategy to Strengthen Resilience of Canada's Healthcare Supply Chain.

Healthcare quarterly (Toronto, Ont.)·2026

An "Early Warning" Risk Assessment Strategy to Enable Proactive Management of Supply Shortages in Canada.

Healthcare quarterly (Toronto, Ont.)·2026

Neurological and functional recovery after supplementary motor area glioma resection: A 15-year single-center cohort study.

Clinical neurology and neurosurgery·2026

Sacral Neuromodulation in Non-Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety.

Neurourology and urodynamics·2026

Motor-evoked modules obtained from transcranial magnetic stimulation.

Journal of neurophysiology·2026

Enhanced substance P-NK1R signaling in the parabrachial-parasubthalamic pathway promotes hyperalgesia and affective aversion in neuropathic pain.

Acta pharmacologica Sinica·2026

Multi-Omics Integration Reveals That SN-011 Targets JUNB to Upregulate ADGRE5 and Restore Vascular Endothelial Cell Communication in Ischemic Stroke.

Chemical biology & drug design·2026

SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways.

European journal of pain (London, England)·2026

Related Experiment Videos

Getting to the source of schizophrenia

Related Concept Videos

Characterization of [3H]MCL-524, a Potent Dopamine D2 high Receptor Agonist.

The High Affinity Dopamine D2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders.

New Dopamine D2 Receptor Agonist, [3H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.

Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States.

Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.

Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.

Population Avoidable Days: A Novel Approach to an Old Problem.

Ambient Artificial Intelligence Scribes in Healthcare: A Governance Imperative for Canadian Health System Leaders.

Optimizing Opioid Addiction Treatment in Correctional Centres: Learnings From Alberta, Canada.

Toward a Quality Standard for Emergency Departments: A Commentary on Improving Mental Health and Substance Use Care for Youth in Canada.

Advancing a Digitally Enabled Supply Chain as a Strategy to Strengthen Resilience of Canada's Healthcare Supply Chain.

An "Early Warning" Risk Assessment Strategy to Enable Proactive Management of Supply Shortages in Canada.

Neurological and functional recovery after supplementary motor area glioma resection: A 15-year single-center cohort study.

Sacral Neuromodulation in Non-Neurogenic Lower Urinary Tract Symptoms: Clinical Efficacy and Safety.

Motor-evoked modules obtained from transcranial magnetic stimulation.

Enhanced substance P-NK1R signaling in the parabrachial-parasubthalamic pathway promotes hyperalgesia and affective aversion in neuropathic pain.

Multi-Omics Integration Reveals That SN-011 Targets JUNB to Upregulate ADGRE5 and Restore Vascular Endothelial Cell Communication in Ischemic Stroke.

SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways.

Related Experiment Videos

Getting to the source of schizophrenia

Related Concept Videos

Related Articles